Number of shares outstanding for Arrowhead Pharmaceuticals (ARWR)

Number of shares outstanding as of September 2024 : 124,199,000

According to Arrowhead Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 124,199,000. At the end of 2024 the company had 124,199,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Arrowhead Pharmaceuticals from 2011 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.12 B	15.63%
2023	0.10 B	1.2%
2022	0.10 B	1.54%
2021	0.10 B	1.73%
2020	0.10 B	5.84%
2019	97.09 M	6.58%
2018	91.09 M	21.73%
2017	74.83 M	4.74%
2016	71.44 M	19.98%
2015	59.54 M	8.88%
2014	54.69 M	44.91%
2013	37.74 M	167.41%
2012	14.11 M	39.45%
2011	10.12 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Alnylam Pharmaceuticals ALNY	126,733,000	2.04%	🇺🇸 USA
Dicerna Pharmaceuticals DRNA	73,916,400	-40.49%	🇺🇸 USA
Ligand Pharmaceuticals LGND	18,028,000	-85.48%	🇺🇸 USA
Inovio Pharmaceuticals INO	27,197,802	-78.10%	🇺🇸 USA
Johnson & Johnson JNJ	2,406,800,000	1,837.86%	🇺🇸 USA
Moderna MRNA	384,000,000	209.18%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions